Table 2 Characteristics of included studies
From: Should oral anticoagulant therapy be continued during dental extraction? A meta-analysis
Study | Country | No.(T/C)a | Design | Anticoagulants | Average age (mean ± SD or mean (range)) |
|---|---|---|---|---|---|
Borea (1993) [21] | Italy | 30(15/15) | RCT | NRb | T: 62.7 ± 6.1 C: 61.1 ± 10 |
Gaspar (1997) [23] | Israel | 47(32/15) | CCT | Vitamin K inhibitor | T: 61.1(34–85) C: 53.4(35–72) |
Devani (1998) [7] | UK | 65(33/32) | CCT | Warfarin | T: 62.3(30–82) C: 61.3(32–81) |
Evans (2002) [16] | UK | 109(57/52) | RCT | Warfarin | T: 67(36–92) C: 66 (30–93) |
Al-Mubarak (2007) [4] | Saudi Arabia | 214(110/114) | RCT | Warfarin | T: 51.7 ± 14.7 53.1 ± 13.7 |
C: 52.3 ± 14.3 48.7 ± 13.1 | |||||
Duan XQ (2010) [22] | China | 116(67/49) | RCT | warfarin | T: 59.5 ± 12.6 C: 61.5 ± 11.3 |